Literature DB >> 16050511

Molecular epidemiology of African and Asian Crimean-Congo haemorrhagic fever isolates.

F J Burt1, R Swanepoel.   

Abstract

Phylogenetic relationships were examined for 70 Crimean-Congo haemorrhagic fever (CCHF) isolates from southern, central and West Africa, the Middle East and Greece using sequence data determined for a region of the S segment of the genome. Analysis revealed up to 18% genetic differences. Tree topology supports previous evidence for the existence of three groups of genetically related isolates, A, B and C. Within group A there are two clades: an African clade and a predominantly Asian clade comprising isolates from Pakistan, China, Iran, Russia and Madagascar. Group B includes isolates from southern and West Africa and Iran, and group C includes a single isolate from Greece. Despite the potential which exists for dispersal of the virus between Africa and Eurasia, it appears that circulation of the virus is largely compartmentalized within the two land masses, and the inference is that the geographic distribution of phylogenetic groups is related to the distribution and dispersal of tick vectors of the virus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16050511      PMCID: PMC2870293          DOI: 10.1017/s0950268805003730

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  Crimean-Congo hemorrhagic fever virus activates endothelial cells.

Authors:  Anne-Marie Connolly-Andersen; Guido Moll; Cecilia Andersson; Sara Akerström; Helen Karlberg; Iyadh Douagi; Ali Mirazimi
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Crimean-Congo hemorrhagic fever virus genomics and global diversity.

Authors:  Varough M Deyde; Marina L Khristova; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus.

Authors:  S M Ghiasi; A H Salmanian; S Chinikar; S Zakeri
Journal:  Clin Vaccine Immunol       Date:  2011-10-19

Review 4.  The role of ticks in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus: A review of published field and laboratory studies.

Authors:  Aysen Gargili; Agustin Estrada-Peña; Jessica R Spengler; Alexander Lukashev; Patricia A Nuttall; Dennis A Bente
Journal:  Antiviral Res       Date:  2017-06-01       Impact factor: 5.970

5.  Basolateral entry and release of Crimean-Congo hemorrhagic fever virus in polarized MDCK-1 cells.

Authors:  Anne-Marie Connolly-Andersen; Karl-Erik Magnusson; Ali Mirazimi
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

6.  Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey.

Authors:  Hürrem Bodur; Esragül Akinci; Sibel Ascioglu; Pinar Öngürü; Yavuz Uyar
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

7.  First international external quality assessment of molecular detection of Crimean-Congo hemorrhagic fever virus.

Authors:  Camille Escadafal; Stephan Olschläger; Tatjana Avšič-Županc; Anna Papa; Jessica Vanhomwegen; Roman Wölfel; Ali Mirazimi; Anette Teichmann; Oliver Donoso-Mantke; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2012-06-26

8.  Detection of IgG antibody against Crimean-Congo haemorrhagic fever virus using ELISA with recombinant nucleoprotein antigens from genetically diverse strains.

Authors:  A Rangunwala; R R Samudzi; F J Burt
Journal:  Epidemiol Infect       Date:  2013-12-13       Impact factor: 4.434

9.  Next-generation sequencing of southern African Crimean-Congo haemorrhagic fever virus isolates reveals a high frequency of M segment reassortment.

Authors:  D Goedhals; P A Bester; J T Paweska; R Swanepoel; F J Burt
Journal:  Epidemiol Infect       Date:  2014-05-01       Impact factor: 4.434

10.  Genetic analysis and epidemiology of Crimean Congo Hemorrhagic fever viruses in Baluchistan province of Pakistan.

Authors:  Muhammad Masroor Alam; Adnan Khurshid; Salmaan Sharif; Shahzad Shaukat; Muhammad Suleman Rana; Mehar Angez; Syed Sohail Zahoor Zaidi
Journal:  BMC Infect Dis       Date:  2013-05-04       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.